Donor cell leukemia: A critical review

Leukemia and Lymphoma

Volumn 48, Issue 1, 2007, Pages 25-38

  Ruiz Argüelles, Guillermo ^a,b   Ruiz Argüelles, Alejandro ^b   Garcés Eisele, Javier ^b,c  

^a CENTRO DE HEMATOLOGÍA Y MEDICINA INTERNA DE PUEBLA   (Mexico)

^b Laboratorios Clinicos de Puebla   (Mexico)

^c UNIVERSIDAD DE LAS AMÉRICAS PUEBLA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ALLELE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOGENEIC STEM CELL TRANSPLANTATION; CANCER CELL; CELL DIVISION; CELL FUSION; CHEMICAL MUTAGENESIS; CYTOGENETICS; DONOR CELL LEUKEMIA; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC MARKER; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOSURVEILLANCE; INCIDENCE; LABORATORY TEST; LEUKEMIA; LEUKEMOGENESIS; LYMPHOID CELL; MALIGNANT TRANSFORMATION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SHORT TANDEM REPEAT; SINGLE NUCLEOTIDE POLYMORPHISM; T CELL LEUKEMIA; VARIABLE NUMBER OF TANDEM REPEAT; ALLOTRANSPLANTATION; CELL TRANSFORMATION; DONOR;

CELL TRANSFORMATION, NEOPLASTIC; HUMANS; LEUKEMIA; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34247243252     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190601003462     Document Type: Review

References (137)

1. Reichard, K. K., Zhang, Q. Y., Sanchez, L., Hozier, J., Viswanatha, D. and Foucar, K. (2006) Acute myeloid leukemia of donor origin after allogeneic bone marrow transplantation for precursor T-cell acute lymphoblastic leukemia: Case report and review of the literature. Am J Hematol, 81, pp. 178-185.
2. Hertenstein, B., Hambach, L., Bacigalupo, A., Schmitz, N., McCann, S. and Slavin, S. (2005) Development of leukemia in donor cells after allogeneic stem cell transplantation - a survey of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica, 90, pp. 969-975.
3. Ruiz-Argüelles, G. J., Ruiz-Delgado, G. J., Garcís-Eisele, J., Ruiz-Argüelles, A., Pérez-Romano, B. and Reyes-Näez, V. (2006) Donor cell leukemia after non-myeloablative allogeneic stem cell transplantation: A single institution experience. Leuk Lymphoma, 47, pp. 1952-1955.
4. Fialkow, P. J., Thomas, E. D., Bryant, J. I. and Neiman, P. E. (1971) Leukaemic transformation of engrafted human marrow cells in vivo. Lancet, 1, pp. 251-255.
5. Thomas, E. D., Bryant, J. I., Buckner, C. D., Clift, R. A., Fefer, A. and Johnson, F. L. (1972) Leukaemic transformation of engrafted human marrow cells in vivo. Lancet, 1, pp. 1310-1313.
6. Goh, K. and Klemperer, M. R. (1977) In vivo leukemic transformation: cytogenetic evidence of in vivo leukemic transformation of engrafted marrow cells. Am J Hematol, 2, pp. 283-290.
7. Elfenbein, G. J., Brogaonkar, D. S., Bias, W. B., Burns, W. H., Saral, R. and Sensenbrenner, L. L. (1978) Cytogenetic evidence for recurrence of acute myelogenous leukemia after allogeneic bone marrow transplantation in donor hematopoietic cells. Blood, 52, pp. 627-636.
8. Newburger, P. E., Latt, S. A., Pesando, J. M., Gustashaw, K., Powers, M., Chaganti, R. S. and O'Reilly, R. J. (1981) Leukemia relapse in donor cells after allogeneic bone-marrow transplantation. N Engl J Med, 304, pp. 712-714.
9. Marmont, A., Frassoni, F., Bacigalupo, A., Podesta, M., Piaggio, G. and Van Lint, M. T. (1984) Recurrence of Ph'-positive leukemia in donor cells after marrow transplantation for chronic granulocytic leukemia. N Engl J Med, 310, pp. 903-906.
10. McCann, S. R., Lawler, M., Humphries, P., Bacigalupo, A., Podesta, M. and Frassoni, F. (1992) Recurrence of Philadelphia chromosome-positive leukemia in donor cells after marrow transplantation for chronic granulocytic leukemia: Confirmation by microsatellite studies. Blood, 79, pp. 2803-2805.
11. Smith, J. L., Heerema, N. A. and Provisor, A. J. (1985) Leukaemic transformation of engrafted bone marrow cells. Br J Haematol, 60, pp. 415-422.
12. Witherspoon, R. P., Schubach, W., Neiman, P., Martin, P. and Thomas, E. D. (1985) Donor cell leukemia developing six years after marrow grafting for acute leukemia. Blood, 65, pp. 1172-1174.
13. Zaccaria, A., Rosti, G., Testoni, N., Arnold, R., Bandini, G. and Becher, R. (1987) Chromosome studies in patients with acute nonlymphocytic or acute lymphocytic leukemia submitted to bone marrow transplantation - results of a European cooperative study. Cancer Genet Cytogenet, 26, pp. 51-58.
14. Schmitz, N., Johannson, W., Schmidt, G., von der Helm, K. and Loffler, H. (1987) Recurrence of acute lymphoblastic leukemia in donor cells after allogeneic marrow transplantation associated with a deletion of the long arm of chromosome 6. Blood, 70, pp. 1099-1104.
15. Feig, S. A., Dreazen, O., Simon, M., Wiley, F., Schreck, R. and Gale, R. P. (1988) B cell acute lymphoblastic leukemia (ALL) in donor cells following bone marrow transplantation for T cell ALL. Bone Marrow Transplant, 3, pp. 331-337.
16. Browne, P. V., Lawler, M., Humphries, P. and McCann, S. R. (1991) Donor-cell leukemia after bone marrow transplantation for severe aplastic anemia. N Engl J Med, 325, pp. 710-713.
17. Cullis, J. O., Marks, D. I., Schwarer, A. P., Barrett, A. J., Hows, J. M., Swirsky, D. M. and Goldman, J. M. (1992) Relapse into blast crisis following bone marrow transplantation for chronic phase chronic myeloid leukaemia: A report of five cases. Br J Haematol, 81, pp. 378-382.
18. Mouratidou, M., Sotiropoulos, D., Deremitzaki, K., Spathas, D. H., Hoffbrand, A. V. and Prentice, H. G. (1993) Recurrence of acute leukemia in donor cells after bone marrow transplantation: Documentation by in situ DNA hybridization. Bone Marrow Transplant, 12, pp. 77-80.
19. Cransac, M., Boiron, J. M., Merel, P., Cony-Makhoul, P., Marit, G. and Bernard, P. (1993) Burkitt-type acute lymphoblastic leukemia in donor cells after allogeneic bone marrow transplantation for acute nonlymphoblastic leukemia. Transplantation, 56, pp. 120-123.
20. Katz, F., Reeves, B. R., Alexander, S., Kearney, L. and Chessells, J. (1993) Leukaemia arising in donor cells following allogeneic bone marrow transplantation for beta thalassaemia demonstrated by immunological, DNA and molecular cytogenetic analysis. Br J Haematol, 85, pp. 326-331.
21. Lowsky, R., Fyles, G., Minden, M., Lipton, J., Meharchand, J. and Tejpar, I. (1996) Detection of donor cell derived acute myelogenous leukaemia in a patient transplanted for chronic myelogenous leukaemia using fluorescence in situ hybridization. Br J Haematol, 93, pp. 163-165.
22. Cooley, L. D., Sears, D. A., Udden, M. M., Harrison, W. R. and Baker, K. R. (2000) Donor cell leukemia: Report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature. Am J Hematol, 63, pp. 46-53.
23. Hambach, L., Eder, M., Dammann, E., Battmer, K., Stucki, A. and Heil, G. (2001) Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplant, 28, pp. 705-707.
24. Lawler, M., Locasciulli, A., Longoni, D., Schiro, R. and McCann, S. R. (2002) Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia. Bone Marrow Transplant, 29, pp. 453-456.
25. Au, W. Y., Chan, E. C., Siu, L. L., Lau, T. C., Lie, A. K., Ma, S. K. and Kwong, Y. L. (2002) Leukaemic relapse of donor origin after allogeneic bone marrow transplantation from a donor who later developed bronchogenic carcinoma. Br J Haematol, 119, pp. 777-780.
26. Gopcsa, L., Barta, A., Banyai, A., Konya, M., Pajor, L., Foldi, J. and Paloczi, K. (2002) Acute myeloid leukaemia of donor cell origin developing 5 years after allogeneic bone marrow transplantation for chronic myeloid leukaemia. Bone Marrow Transplant, 29, pp. 449-452.
27. Brunstein, C. G., Hirsch, B. A., Hammerschmidt, D., McGlennen, R. C., Nguyen, P. L. and Verfaillie, C. M. (2002) Leukemia in donor cells after allogeneic hematopoietic stem cell transplant. Bone Marrow Transplant, 29, pp. 999-1003.
28. Komeno, Y., Kanda, Y., Kandabashi, K., Kawazu, M., Goyama, S. and Takeshita, M. (2003) Reduced-intensity bone marrow transplantation from an alternative unrelated donor for myelodysplastic syndrome of first-donor origin. Am J Hematol, 72, pp. 220-222.
29. Bielorai, B., Deeg, H. J., Weintraub, M., Neumann, Y., Rosner, E. and Amariglio, N. (2003) B-cell lymphoma developing in the donor 9 years after donor-origin acute myeloid leukemia post bone marrow transplantation. Bone Marrow Transplant, 31, pp. 931-934.
30. Haltrich, I., Muller, J., Szabo, J., Kovacs, G., Koos, R. and Poros, A. (2003) Donor-cell myelodysplastic syndrome developing 13 years after marrow grafting for aplastic anemia. Cancer Genet Cytogenet, 142, pp. 124-128.
31. Au, W. Y., Lam, C. C., Lie, A. K., Pang, A. and Kwong, Y. L. (2003) T-cell large granular lymphocyte leukemia of donor origin after allogeneic bone marrow transplantation. Am J Clin Pathol, 120, pp. 626-630.
32. McCann, S. and Wright, E. (2003) Donor leukaemia: Perhaps a more common occurrence than we thought!. Bone Marrow Transplant, 32, pp. 455-457.
33. Matsunaga, T., Murase, K., Yoshida, M., Fujimi, A., Iyama, S. and Kuribayashi, K. (2005) Donor cell derived acute myeloid leukemia after allogeneic cord blood transplantation in a patient with adult T-cell lymphoma. Am J Hematol, 79, pp. 294-298.
34. Fraser, C. J., Hirsch, B. A., Dayton, V., Creer, M. H., Neglia, J. P., Wagner, J. E. and Baker, K. S. (2005) First report of donor cell-derived acute leukemia as a complication of umbilical cord blood transplantation. Blood, 106, pp. 4377-4380.
35. Ataergin, S., Arpaci, F., Cetil, T., Guran, S., Yakicier, C., Beyzadeoglu, M. and Ozet, A. (2006) Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia. Am J Hematol, 81, pp. 370-373.
36. Sala-Torra, O., Hanna, C., Loken, M. R., Flowers, M ED, Maris, M. and Ladne, P. A. (2006) Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantation. Biol Blood Marrow Transpl, 12, pp. 511-517.
37. Greaves, M. F. (2006) Cord blood donor cell leukemia in recipients. Leukemia
38. Sparkes, M. C., Crist, M. L., Sparkes, R. S., Gale, R. P. and Feig, S. A. (1977) Gene markers in human bone marrow transplantation. Vox Sang, 33, pp. 202-205.
39. Mathe, G., Amiel, J. L., Schwarzenberg, L., Cattan, A., Schneider, M. and Devries, M. J. (1965) Successful allogenic bone marrow transplantation in man: Chimerism, induced specific tolerance and possible anti-leukemic effects. Blood, 25, pp. 179-196.
40. Blume, K. G., Beutler, E., Bross, K. J., Schmidt, G. M., Spruce, W. E. and Teplitz, R. L. (1980) Genetic markers in human bone marrow transplantation. Am J Hum Genet, 32, pp. 414-419.
41. Witherspoon, R. P., Schanfield, M. S., Storb, R., Thomas, E. D. and Giblett, E. R. (1978) Immunoglobulin production of donor origin after marrow transplantation for acute leukemia or aplastic anemia. Transplantation, 26, pp. 407-408.
42. Schattenberg, A., De Witte, T., Salden, M., Vet, J., Van Dijk, B. and Smeets, D. (1989) Mixed hematopoietic chimerism after allogeneic transplantation with lymphocyte-depleted bone marrow is not associated with a higher incidence of relapse. Blood, 73, pp. 1367-1372.
43. Bolan, C. D., Leitman, S. F., Griffith, L. M., Wesley, R. A., Procter, J. L. and Stroncek, D. F. (2001) Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. Blood, 98, pp. 1687-1694.
44. Thiede, C. (2004) Diagnostic chimerism analysis after allogeneic stem cell transplantation: New methods and markers. Am J Pharmacogenomics, 4, pp. 177-187.
45. Stein, J., Zimmerman, P. A., Kochera, M., Strandjord, S., Golden, W. and Simon, M. (1989) Origin of leukemic relapse after bone marrow transplantation: Comparison of cytogenetic and molecular analyses. Blood, 73, pp. 2033-2040.
46. Lawler, S. D., Baker, M. C., Harris, H. and Morgenstern, G. R. (1984) Cytogenetic studies on recipients of allogeneic bone marrow using the sex chromosomes as markers of cellular origin. Br J Haematol, 56, pp. 431-443.
47. Mielcarek, M., Bryant, E., Loken, M., Torok-Storb, B. and Storb, R. (1999) Haemopoietic reconstitution by donor-derived myelodysplastic progenitor cells after haemopoietic stem cell transplantation. Br J Haematol, 105, pp. 361-365.
48. Dewald, G. W., Schad, C. R., Christensen, E. R., Law, M. E., Zinsmeister, A. R. and Stalboerger, P. G. (1993) Fluorescence in situ hybridization with X and Y chromosome probes for cytogenetic studies on bone marrow cells after opposite sex transplantation. Bone Marrow Transplant, 12, pp. 149-154.
49. Buno, I., Nava, P., Simon, A., Gonzalez-Rivera, M., Jimenez, J. L. and Balsalobre, P. (2005) A comparison of fluorescent in situ hybridization and multiplex short tandem repeat polymerase chain reaction for quantifying chimerism after stem cell transplantation. Haematologica, 90, pp. 1373-1379.
50. Jolkowska, J., Pieczonka, A., Strabel, T., Boruczkowski, D., Wachowiak, J., Bader, P. and Witt, M. (2005) Hematopoietic chimerism after allogeneic stem cell transplantation: A comparison of quantitative analysis by automated DNA sizing and fluorescent in situ hybridization. BMC Blood Disord, 5, pp. 1-6.
51. Lo, Y. M., Tein, M. S., Lau, T. K., Haines, C. J., Leung, T. N. and Poon, P. M. (1998) Quantitative analysis of fetal DNA in maternal plasma and serum: Implications for noninvasive prenatal diagnosis. Am J Hum Genet, 62, pp. 768-775.
52. Fehse, B., Chukhlovin, A., Kuhlcke, K., Marinetz, O., Vorwig, O. and Renges, H. (2001) Real-time quantitative Y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation. J Hematother Stem Cell Res, 10, pp. 419-425.
53. Ugozzoli, L., Yam, P., Petz, L. D., Ferrara, G. B., Champlin, R. E. and Forman, S. J. (1991) Amplification by the polymerase chain reaction of hypervariable regions of the human genome for evaluation of chimerism after bone marrow transplantation. Blood, 77, pp. 1607-1615.
54. Boerwinkle, E., Xiong, W. J., Fourest, E. and Chan, L. (1989) Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: Application to the apolipoprotein B 3' hypervariable region. Proc Natl Acad Sci USA, 86, pp. 212-216.
55. Schichman, S. A., Suess, P., Vertino, A. M. and Gray, P. S. (2002) Comparison of short tandem repeat and variable number tandem repeat genetic markers for quantitative determination of allogeneic bone marrow transplant engraftment. Bone Marrow Transplant, 29, pp. 243-248.
56. Lawler, M., Humphries, P. and McCann, S. R. (1991) Evaluation of mixed chimerism by in vitro amplification of dinucleotide repeat sequences using the polymerase chain reaction. Blood, 77, pp. 2504-2514.
57. Scharf, S. J., Smith, A. G., Hansen, J. A., McFarland, C. and Erlich, H. A. (1995) Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers. Blood, 85, pp. 1954-1963.
58. Kristt, D., Israeli, M., Narinski, R., Yaniv, I., Stein, J. and Klein, T. (2005) Hematopoietic chimerism monitoring based on STRs: Quantitative platform performance on sequential samples. J Biomol Tech, 16, pp. 380-391.
59. Hochberg, E. P., Miklos, D. B., Neuberg, D., Eichner, D. A., McLaughlin, S. F. and Mattes-Ritz, A. (2003) A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation. Blood, 101, pp. 363-369.
60. Roth, M. S., Antin, J. H., Bingham, E. L. and Ginsburg, D. (1990) Use of polymerase chain reaction-detected sequence polymorphisms to document engraftment following allogeneic bone marrow transplantation. Transplantation, 49, pp. 714-720.
61. Kroger, N., Zagrivnaja, M., Schwartz, S., Badbaran, A., Zabelina, T. and Lioznov, M. (2006) Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myeloma. Exp Hematol, 34, pp. 688-694.
62. Alizadeh, M., Bernard, M., Danic, B., Dauriac, C., Birebent, B. and Lapart, C. (2002) Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. Blood, 99, pp. 4618-4625.
63. Bader, P., Niethammer, D., Willasch, A., Kreyenberg, H. and Klingebiel, T. (2005) How and when should we monitor chimerism after allogeneic stem cell transplantation?. Bone Marrow Transplant, 35, pp. 107-119.
64. Guettier, C., Sebagh, M., Buard, J., Feneux, D., Ortin-Serrano, M. and Gigou, M. (2005) Male cell microchimerism in normal and diseased female livers from fetal life to adulthood. Hepatology, 42, pp. 35-43.
65. Maloney, S., Smith, A., Furst, D. E., Myerson, D., Rupert, K., Evans, P. C. and Nelson, J. L. (1999) Microchimerism of maternal origin persists into adult life. J Clin Invest, 104, pp. 41-47.
66. Uehara, S., Nata, M., Nagae, M., Sagisaka, K., Okamura, K. and Yajima, A. (1995) Molecular biologic analyses of tetragametic chimerism in a true hermaphrodite with 46,XX/46,XY. Fertil Steril, 63, pp. 189-192.
67. Beck, O., Seidl, C., Lehrnbecher, T., Kreyenberg, H., Schwabe, D. and Klingebiel, T. (2006) Quantification of chimerism within peripheral blood, bone marrow and purified leukocyte subsets: Comparison of singleplex and multiplex PCR amplification of short tandem repeat (STR) loci. Eur J Haematol, 76, pp. 237-244.
68. Najfeld, V., Burnett, W., Vlachos, A., Scigliano, E., Isola, L. and Fruchtman, S. (1997) Interphase FISH analysis of sex-mismatched BMT utilizing dual color XY probes. Bone Marrow Transplant, 19, pp. 829-834.
69. Antin, J. H., Childs, R., Filipovich, A. H., Giralt, S., Mackinnon, S., Spitzer, T. and Weisdorf, D. (2001) Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant, 7, pp. 473-485.
70. Chou, P. M., Olszewski, M., Huang, W., Silva, M. and Kletzel, M. (2003) Platelet chimerism by polymerase chain reaction (PCR) utilizing variable number of tandem repeats (VNTR) in allogeneic stem cell transplant in children: A new novel approach to full chimerism analysis. Bone Marrow Transplant, 32, pp. 825-828.
71. Lanfranchi, A., Verardi, R., Tettoni, K., Neva, A., Mazzolari, E. and Pennacchio, M. (2000) Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency. Haematologica, 85, pp. 41-46.
72. Yamazaki, S., Takahashi, H., Fujii, H., Miyamae, T., Mori, M. and Fujioka, K. (2003) Split chimerism after allogeneic bone marrow transplantation in Chediak-Higashi syndrome. Bone Marrow Transplant, 31, pp. 137-140.
73. Holmgren, L., Szeles, A., Rajnavolgyi, E., Folkman, J., Klein, G., Ernberg, I. and Falk, K. I. (1999) Horizontal transfer of DNA by the uptake of apoptotic bodies. Blood, 93, pp. 3956-3963.
74. Bergsmedh, A., Szeles, A., Henriksson, M., Bratt, A., Folkman, M. J., Spetz, A. L. and Holmgren, L. (2001) Horizontal transfer of oncogenes by uptake of apoptotic bodies. Proc Natl Acad Sci USA, 98, pp. 6407-6411.
75. Bergsmedh, A., Ehnfors, J., Kawane, K., Motoyama, N., Nagata, S. and Holmgren, L. (2006) DNase II and the Chk2 DNA damage pathway form a genetic barrier blocking replication of horizontally transferred DNA. Mol Cancer Res, 4, pp. 187-195.
76. Mortensen, K., Lichtenberg, J., Thomsen, P. D. and Larsson, L. I. (2004) Spontaneous fusion between cancer cells and endothelial cells. Cell Mol Life Sci, 61, pp. 2125-2131.
77. Pawelek, J. M. (2005) Tumour-cell fusion as a source of myeloid traits in cancer. Lancet Oncol, 6, pp. 988-993.
78. Chakraborty, A., Lazova, R., Davies, S., Backvall, H., Ponten, F., Brash, D. and Pawelek, J. (2004) Donor DNA in a renal cell carcinoma metastasis from a bone marrow transplant recipient. Bone Marrow Transplant, 34, pp. 183-186.
79. Dewald, G., Stallard, R., Saadi, A Al, Arnold, S., Bader, P. I. and Blough, R. (1998) A multicenter investigation with interphase fluorescence in situ hybridization using X- and Y-chromosome probes. Am J Med Genet, 76, pp. 318-326.
80. Buno, I., Anta, B., Moreno-Lopez, E., Balsalobre, P., Balas, A. and Garcia-Sanchez, F. (2003) Lineage-specific chimaerism quantification after T-cell depleted peripheral blood stem cell transplantation. Leuk Lymphoma, 44, pp. 659-667.
81. Herens, C., Brasseur, E., Jamar, M., Vierset, L., Schoenen, I. and Koulischer, L. (1999) Loss of the Y chromosome in bone marrow cells: results on 1907 consecutive cases of leukaemia and preleukaemia. Clin Lab Haematol, 21, pp. 17-20.
82. Wiktor, A., Rybicki, B. A., Piao, Z. S., Shurafa, M., Barthel, B., Maeda, K. and Van Dyke, D. L. (2000) Clinical significance of Y chromosome loss in hematologic disease. Genes Chromosomes Cancer, 27, pp. 11-16.
83. Spinelli, O., Giussani, U., Borleri, G., Lazzari, M., Michelato, A. and Dotti, G. (2000) Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation. Haematologica, 85, pp. 1153-1157.
84. Wong, K. F., Chan, J. K., Yu, P. H. and So, C. C. (1999) A man with natural killer cell lymphoma showing 46,XX and deletion 6q. Cancer Genet Cytogenet, 112, pp. 165-168.
85. Mossallam, G. I., Smith, A. G. and McFarland, C. (2005) Comparison of variable number tandem repeat and short tandem repeat genetic markers for qualitative and quantitative chimerism analysis post allogeneic stem cell transplantation. J Egypt Natl Canc Inst, 17, pp. 103-113.
86. Gill, P., Whitaker, J., Flaxman, C., Brown, N. and Buckleton, J. (2000) An investigation of the rigor of interpretation rules for STRs derived from less than 100 pg of DNA. Forensic Sci Int, 112, pp. 17-40.
87. Gill, P., Curran, J. and Elliot, K. (2005) A graphical simulation model of the entire DNA process associated with the analysis of short tandem repeat loci. Nucleic Acids Res, 33, pp. 632-643.
88. Hauge, X. Y. and Litt, M. (1993) A study of the origin of 'shadow bands' seen when typing dinucleotide repeat polymorphisms by the PCR. Hum Mol Genet, 2, pp. 411-415.
89. Walsh, P. S., Fildes, N. J. and Reynolds, R. (1996) Sequence analysis and characterization of stutter products at the tetranucleotide repeat locus vWA. Nucleic Acids Res, 24, pp. 2807-2812.
90. Weber, J. L. and May, P. E. (1989) Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet, 44, pp. 388-396.
91. Levinson, G. and Gutman, G. A. (1987) High frequencies of short frameshifts in poly-CA/TG tandem repeats borne by bacteriophage M13 in Escherichia coli K-12. Nucleic Acids Res, 15, pp. 5323-5338.
92. Levinson, G. and Gutman, G. A. (1987) Slipped-strand mispairing: A major mechanism for DNA sequence evolution. Mol Biol Evol, 4, pp. 203-221.
93. Schlotterer, C. and Tautz, D. (1992) Slippage synthesis of simple sequence DNA. Nucleic Acids Res, 20, pp. 211-215.
94. Urquhart, A., Chiu, C. T., Clayton, T. M., Downes, T., Frazier, R RE and Jones, S. Multiplex STR systems with fluorescent detection as human identification markers. Proceedings from the 5th International Symposium on Human Identification
95. Gusmao, L., Amorim, A., Prata, M. J., Pereira, L., Lareu, M. V. and Carracedo, A. (1996) Failed PCR amplifications of MBP-STR alleles due to polymorphism in the primer annealing region. Int J Legal Med, 108, pp. 313-315.
96. Lygo, J. E., Johnson, P. E., Holdaway, D. J., Woodroffe, S., Whitaker, J. P. and Clayton, T. M. (1994) The validation of short tandem repeat (STR) loci for use in forensic casework. Int J Leg Med, 107, pp. 77-89.
97. Borst, A., Box, A. T. and Fluit, A. C. (2004) False-positive results and contamination in nucleic acid amplification assays: Suggestions for a prevent and destroy strategy. Eur J Clin Microbiol Infect Dis, 23, pp. 289-299.
98. Kwok, S. and Higuchi, R. (1989) Avoiding false positives with PCR. Nature, 339, pp. 237-238.
99. Technical Working Group on DNA Methods (1995) Guidelines for a quality assurance program for DNA analysis. Crime Laboratory Digest, 22, pp. 21-50.
100. Zhou, M., Sheldon, S., Akel, N. and Killeen, A. A. (1999) Chromosomal aneuploidy in leukemic blast crisis: A potential source of error in interpretation of bone marrow engraftment analysis by VNTR amplification. Mol Diagn, 4, pp. 153-157.
101. Schichman, S. A., Lin, P., Gilbrech, L. J., Gray, P. S., Wilson, C. S. and Sawyer, J. R. (2002) Bone marrow transplant engraftment analysis with loss of an informative allele. J Mol Diagn, 4, pp. 230-232.
102. Rubocki, R. J., Duffy, K. J., Shepard, K. L., McCue, B. J., Shepherd, S. J. and Wisecarver, J. L. (2000) Loss of heterozygosity detected in a short tandem repeat (STR) locus commonly used for human DNA identification. J Forensic Sci, 45, pp. 1087-1089.
103. Stark, B., Jeison, M., Gobuzov, R., Krug, H., Glaser-Gabay, L. and Luria, D. (2001) Near haploid childhood acute lymphoblastic leukemia masked by hyperdiploid line: Detection by fluorescence in situ hybridization. Cancer Genet Cytogenet, 128, pp. 108-113.
104. Gancberg, D., Dargent, J. L., Verhest, A., Kentos, A., Feremans, W., Lohrisch, C. and Kornreich, A. (2001) Near haploid blast phase in a chronic myeloid leukemia detected by fluorescence in situ hybridization using a BCR-ABL probe. Cancer Genet Cytogenet, 128, pp. 172-174.
105. Cibull, M. L., Thompson, M. E., Smith, L., Jennings, C. D., Doukas, M. A., Pavlik, E. J. and Powell, D. E. (1987) Marked hypodiploidy in blast phase chronic myelogenous leukemia: Report of a case and review of the literature. Am J Hematol, 24, pp. 293-299.
106. Weber, J. L., David, D., Heil, J., Fan, Y., Zhao, C. and Marth, G. (2002) Human diallelic insertion/deletion polymorphisms. Am J Hum Genet, 71, pp. 854-862.
107. Bhangale, T. R., Rieder, M. J., Livingston, R. J. and Nickerson, D. A. (2005) Comprehensive identification and characterization of diallelic insertion-deletion polymorphisms in 330 human candidate genes. Hum Mol Genet, 14, pp. 59-69.
108. Maas, F., Schaap, N., Kolen, S., Zoetbrood, A., Buno, I. and Dolstra, H. (2003) Quantification of donor and recipient hemopoietic cells by real-time PCR of single nucleotide polymorphisms. Leukemia, 17, pp. 621-629.
109. Sachidanandam, R., Weissman, D., Schmidt, S. C., Kakol, J. M., Stein, L. D. and Marth, G. (2001) A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature, 409, pp. 928-933.
110. Agrawal, S., Khan, F., Talwar, S. and Nityanand, S. (2004) Short tandem repeat technology has diverse applications: Individual identification, phylogenetic reconstruction and chimerism based post haematopoietic stem cell transplantation graft monitoring. Indian J Med Sci, 58, pp. 297-304.
111. Thiede, C., Bornhauser, M. and Ehninger, G. (2004) Evaluation of STR informativity for chimerism testing-comparative analysis of 27 STR systems in 203 matched related donor recipient pairs. Leukemia, 18, pp. 248-254.
112. van Leeuwen, J. E., van Tol, M. J., Bodzinga, B. G., Wijnen, J. T., van der Keur, M. and Joosten, A. M. (1991) Detection of mixed chimaerism in flow-sorted cell subpopulations by PCR-amplified VNTR markers after allogeneic bone marrow transplantation. Br J Haematol, 79, pp. 218-225.
113. Walker, S. E. (1982) Early appearance of abnormally migrating serum IgM in control and cyclophosphamide-treated NZB/NZW mice. J Rheumatol, 9, pp. 183-188.
114. Diebold, J. (1984) Reactive lymph-node hyperplasia and pseudolymphomas with hypergammaglobulinemia. II. Pseudolymphoma and prelymphoma Ann Pathol, 4, pp. 3-17.
115. Talal, N. and Bunim, J. J. (1964) The development of malignant lymphoma in the course of Sjøgren's syndrome. Am J Med, 36, pp. 529-540.
116. Kowenz-Leutz, E. and Leutz, A. (1999) A C/EBP-beta isoform recruits the SWI/SNF complex to activate myeloid genes. Molecular Cell, 4, pp. 735-743.
117. Calkhoven, C. F., Muller, C. and Leutz, A. (2000) Translational control of C/EBP alpha and C/EBP beta isoform expression. Genes Dev, 14, pp. 1920-1932.
118. Pedersen, T. A., Kowenz-Leutz, E., Leutz, A. and Nerlov, C. (2001) Cooperation between C/EBPalpha TBP/TFIIB and SWI/SNF recruiting domains is required for adipocyte differentiation. Genes Dev, 15, pp. 3208-3216.
119. Calkhoven, C. F., Muller, C. and Leutz, A. (2002) Translational control of gene expression and disease. Trends Mol Med, 8, pp. 577-583.
120. Calkhoven, C. F., Muller, C., Martin, R., Krosl, G., Pietsch, H., Hoang, T. and Leutz, A. (2003) Translational control of SCL-isoform expression in hematopoietic lineage choice. Genes Dev, 17, pp. 959-964.
121. Muller, C., Calkhoven, C. F., Sha, X. and Leutz, A. (2004) The CCAAT enhancer-binding protein alpha (C/EBPalpha) requires a SWI/SNF complex for proliferation arrest. J Biol Chem, 279, pp. 7353-7358.
122. Kowenz-Leutz, E. and Leutz, A. (2004) Ras induces mediator complex exchange on C/EBP beta. Mol Cell, 13, pp. 241-250.
123. Begay, V., Smink, J. and Leutz, A. (2004) Essential requirement of CCAAT/ Enhancer Binding Proteins (C/EBP) in embryogenesis. Mol Cell Biol, 24, pp. 9744-9751.
124. Murugesan, G., Aboudola, S., Szpurka, H., Verbic, M. A., Maciejewski, J. P., Tubbs, R. R. and Hsi, E. D. (2006) Identification of the JAK2 V617F mutation in chronic myeloproliferative disorders using FRET probes and melting curve analysis. Am J Clin Pathol, 125, pp. 625-633.
125. Schuler, F., Hirt, C. and Dolken, G. (2003) Chromosomal translocation t(14;18) in healthy individuals. Semin Cancer Biol, 13, pp. 203-209.
126. Janz, S., Potter, M. and Rabkin, C. S. (2003) Lymphoma- and leukemia-associated chromosomal translocation in healthy individuals. Genes Chromosomes Cancer, 36, pp. 211-223.
127. Uckun, F. M., Herman-Hatten, K., Crotty, M. L., Sensel, M. G., Sather, H. N. and Tuel-Ahlgren, L. (1998) Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation. Blood, 92, pp. 810-821.
128. Deeg, H. J. and Socie, G. (1998) Malignancies after hematopoietic stem cell transplantation: Many questions, some answers. Blood, 91, pp. 1833-1844.
129. Weiss, R., Mitrou, P., Arasteh, K., Schuermann, D., Hentrich, M. and Duehrsen, U. (2006) Acquired immunodeficiency syndrome-related lymphoma: simultaneous treatment with combined cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy and highly active antiretroviral therapy is safe and improves survival-results of the German Multicenter Trial. Cancer, 106, pp. 1560-1568.
130. Weissman, I. L., McGrath, M. S. and Tamura, G. (1985) The receptor-mediated leukemogenesis hypothesis: A model of retroviral oncogenesis by viral stimulation of cell-surface receptors. Life Sci Res Rep, 30, pp. 235-249.
131. Bergsmedh, A., Szeles, A., Henriksson, M., Bratt, A., Folkman, M. J., Spetz, A. L. and Holmgren, L. (2001) Horizontal transfer of oncogenes by uptake of apoptotic bodies. Proc Nat Acad Sci USA, 98, pp. 6407-6411.
132. McCann, S. R., Lawler, M. and Bacigalupo, A. (1993) Recurrence of Philadelphia chromosome-positive leukemia in donor cells after bone marrow transplantation for chronic granulocytic leukemia. Leuk Lymphoma, 10, pp. 419-425.
133. Pedersen-Bjergaard, J. (2005) Insight into leukemogenesis from therapy-related leukemia. N Eng J Med, 352, pp. 1591-1594.
134. Karpinets, T. V. and Foy, B. D. (2005) Tumorigenesis: The adaptation of mammalian cells to sustained stress environment by epigenetic alterations and succeeding matched mutations. Carcinogenesis, 26, pp. 1323-1334.
135. Kraut, L., Trebeljahr, G., Thiele, B. and Fauser, A. A. (2005) Donor cell-derived myelodysplastic syndrome in a patient 7 years after unrelated allogeneic HLA-mismatched transplantation for Ph+ chronic myeloid leukemia. Bone Marrow Transplant, 36, p. 737.
136. Turner, S. D. and Alexander, D. R. (2006) Fusion tyrosine kinase mediated signalling pathways in the transformation of haematopoietic cells. Leukemia, 20, pp. 572-582.
137. Haegert, D. G. (2004) Analysis of threshold liability model provides new understanding of causation of autoimmune diseases. Med Hypotheses, 63, pp. 257-261.